$1.24
+0.05 (+3.82%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+3,338.8% upside
Low Target
$23.35
Average Target
$42.48
High Target
$52.53
Current Price
$1.24
Current
$1.24
$1.24
Target
$42.48
$42.48
$23.35
$42.48 avg
$52.53
Scenario Analysis
Bear Case
$23.35
1,790.2%
Low target
Base Case
$42.48
+3,338.8%
Avg target
Bull Case
$52.53
+4,152.4%
High target
Risk/Reward
2.3x
Favorable
Price in Context
52-Week High
$4.87
-74.6% from high
52-Week Low
$0.85
+45.3% from low
Target vs 52W High
$42.48
+773.2% vs high
Next Earnings Report
Nov 10, 2026
2d
until earnings
Earnings in 2 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -11.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +117.3% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.9% |
| MRNA | Hold | 31 | 35% | $149.45 | -41.2% |
| REGN | Buy | 37 | 70% | $76.80 | -91.5% |
| NTRA | Strong Buy | 30 | 90% | $142.91 | -54.0% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -40.7% |